Two-Year Follow-Up of KEYNOTE-365 Cohort D: Pembrolizumab (pembro) Plus Abiraterone Acetate (abi) and Prednisone in Patients With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Abiraterone Acetate;Pembrolizumab;Prednisone
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Two-Year Follow-Up of KEYNOTE-365 Cohort D: Pembrolizumab (pembro) Plus Abiraterone Acetate (abi) and Prednisone in Patients With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer (mCRPC) ### Output: Abiraterone Acetate;Pembrolizumab;Prednisone